IASO206
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IASO206, covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: IASO206 in Patients With Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]